trifluridine drops
Selected indexed studies
- Trifluridine for treatment of mpox infection in drug combinations in ophthalmic cell models. (J Med Virol, 2024) [PMID:38180134]
- Intraocular penetration of trifluridine. (Am J Ophthalmol, 1979) [PMID:110152]
- Monkeypox as an emerging infectious disease: the ophthalmic implications. (Br J Ophthalmol, 2022) [PMID:36216412]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Trifluridine for treatment of mpox infection in drug combinations in ophthalmic cell models. (2024) pubmed
- Intraocular penetration of trifluridine. (1979) pubmed
- Monkeypox as an emerging infectious disease: the ophthalmic implications. (2022) pubmed
- Ocular complications of smallpox vaccination. (2003) pubmed
- Unique Attributes of Guinea Pigs as New Models to Study Ocular Herpes Pathophysiology and Recurrence. (2023) pubmed
- Treatment of ocular-involving monkeypox virus with topical trifluridine and oral tecovirimat in the 2022 monkeypox virus outbreak. (2023) pubmed
- Effect of topical trifluridine on Thygeson's superficial punctate keratitis. (1984) pubmed
- Topical pharmacologic interventions versus placebo for epidemic keratoconjunctivitis. (2022) pubmed
- Arthrographis keratitis mimicking acanthamoeba keratitis. (2004) pubmed
- Antiviral medications and corneal wound healing. (1984) pubmed